SIMILAR PATTERNS OF AMINO ACIDS FOR 2RKF_A_AB1A501_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b3n PROTEIN (KETOACYL
ACYL CARRIER PROTEIN
SYNTHASE 2)


(Escherichia
coli)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
6 LEU A 146
GLY A  11
ALA A  84
ASP A  87
ILE A 170
ALA A 102
None
1.45A 2rkfB-1b3nA:
undetectable
2rkfB-1b3nA:
14.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bhy P64K

(Neisseria
meningitidis)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
6 ALA A 555
ILE A 579
GLY A 538
ILE A 527
ALA A 583
ILE A 565
None
0.98A 2rkfB-1bhyA:
undetectable
2rkfB-1bhyA:
13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.58A 2rkfB-1cziE:
6.9
2rkfB-1cziE:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ecg GLUTAMINE
PHOSPHORIBOSYLPYROPH
OSPHATE
AMIDOTRANSFERASE


(Escherichia
coli)
PF00156
(Pribosyltran)
PF13522
(GATase_6)
6 LEU A  98
ALA A 136
ASP A 140
ILE A 173
ALA A 171
ILE A  96
None
1.38A 2rkfB-1ecgA:
undetectable
2rkfB-1ecgA:
12.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fft UBIQUINOL OXIDASE

(Escherichia
coli)
PF00115
(COX1)
PF00116
(COX2)
PF06481
(COX_ARM)
5 ALA B 104
ILE A 354
GLY A 349
ALA A 356
ILE B 100
None
None
None
HEO  A1002 (-3.3A)
HEO  A1002 (-4.4A)
0.84A 2rkfB-1fftB:
undetectable
2rkfB-1fftB:
16.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ghh DNA-DAMAGE-INDUCIBLE
PROTEIN I


(Escherichia
coli)
PF06183
(DinI)
5 GLY A  54
ALA A  55
ASP A  59
ILE A  63
GLY A  38
None
0.84A 2rkfB-1ghhA:
undetectable
2rkfB-1ghhA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h74 HOMOSERINE KINASE

(Methanocaldococcus
jannaschii)
PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
5 LEU A 112
ASP A  73
GLY A  65
ALA A 108
ILE A 109
None
0.75A 2rkfB-1h74A:
undetectable
2rkfB-1h74A:
15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h74 HOMOSERINE KINASE

(Methanocaldococcus
jannaschii)
PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
6 LEU A 112
GLY A  80
GLY A  65
ILE A  48
ALA A 108
ILE A 109
None
1.04A 2rkfB-1h74A:
undetectable
2rkfB-1h74A:
15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h7w DIHYDROPYRIMIDINE
DEHYDROGENASE


(Sus scrofa)
PF01180
(DHO_dh)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
PF14697
(Fer4_21)
5 ALA A  72
ILE A 101
GLY A 153
ALA A 112
ILE A 104
None
None
SF4  A1026 ( 3.9A)
None
None
0.85A 2rkfB-1h7wA:
undetectable
2rkfB-1h7wA:
7.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.97A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.18A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.19A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.51A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.31A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.79A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.8A)
1.13A 2rkfB-1hvcA:
13.8
2rkfB-1hvcA:
43.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1idt MINOR FMN-DEPENDENT
NITROREDUCTASE


(Escherichia
coli)
PF00881
(Nitroreductase)
5 GLY A  66
ALA A  65
GLY A 166
ALA A 170
ILE A 171
None
None
FMN  A1218 (-3.6A)
None
None
0.88A 2rkfB-1idtA:
undetectable
2rkfB-1idtA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kae HISTIDINOL
DEHYDROGENASE


(Escherichia
coli)
PF00815
(Histidinol_dh)
5 GLY A 227
ALA A 228
ASP A 204
GLY A 196
ILE A 206
None
0.87A 2rkfB-1kaeA:
undetectable
2rkfB-1kaeA:
12.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kbl PYRUVATE PHOSPHATE
DIKINASE


([Clostridium]
symbiosum)
PF00391
(PEP-utilizers)
PF01326
(PPDK_N)
PF02896
(PEP-utilizers_C)
5 LEU A 426
ALA A 456
GLY A 462
ALA A 442
ILE A 445
None
0.87A 2rkfB-1kblA:
undetectable
2rkfB-1kblA:
8.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l1l RIBONUCLEOSIDE
TRIPHOSPHATE
REDUCTASE


(Lactobacillus
leichmannii)
PF02867
(Ribonuc_red_lgC)
6 ALA A 302
ASP A 303
ASP A 300
ILE A 172
ILE A 334
ALA A 168
None
1.33A 2rkfB-1l1lA:
undetectable
2rkfB-1l1lA:
9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ldn L-LACTATE
DEHYDROGENASE


(Geobacillus
stearothermophilus)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
6 LEU A  39
ASP A  77
ILE A  78
GLY A  81
ILE A  51
ILE A  48
None
1.47A 2rkfB-1ldnA:
undetectable
2rkfB-1ldnA:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lgf P450 MONOOXYGENASE

(Amycolatopsis
orientalis)
PF00067
(p450)
6 LEU A 195
ASP A 223
ILE A 210
GLY A 218
ALA A 199
ILE A 198
None
1.41A 2rkfB-1lgfA:
undetectable
2rkfB-1lgfA:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lk5 D-RIBOSE-5-PHOSPHATE
ISOMERASE


(Pyrococcus
horikoshii)
PF06026
(Rib_5-P_isom_A)
5 GLY A 101
ALA A 102
GLY A 207
ILE A  97
ILE A 179
CL  A1001 (-3.4A)
None
None
None
None
0.87A 2rkfB-1lk5A:
undetectable
2rkfB-1lk5A:
17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mpp PEPSIN

(Rhizomucor
pusillus)
PF00026
(Asp)
5 ASP A 215
GLY A 217
ILE A 222
GLY A  76
ILE A 300
None
0.88A 2rkfB-1mppA:
7.4
2rkfB-1mppA:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mpp PEPSIN

(Rhizomucor
pusillus)
PF00026
(Asp)
5 LEU A  30
ASP A  32
GLY A  34
ASP A  37
ILE A 120
None
0.75A 2rkfB-1mppA:
7.4
2rkfB-1mppA:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pix GLUTACONYL-COA
DECARBOXYLASE A
SUBUNIT


(Acidaminococcus
fermentans)
PF01039
(Carboxyl_trans)
5 LEU A 146
GLY A 189
ALA A 211
GLY A 252
ILE A 187
None
0.87A 2rkfB-1pixA:
undetectable
2rkfB-1pixA:
10.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
None
0.85A 2rkfB-1q9pA:
10.4
2rkfB-1q9pA:
82.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rrm LACTALDEHYDE
REDUCTASE


(Escherichia
coli)
PF00465
(Fe-ADH)
6 GLY A  67
ASP A  39
ILE A  36
ILE A 107
ALA A  63
ILE A  64
None
APR  A 389 (-2.7A)
None
None
None
None
1.44A 2rkfB-1rrmA:
undetectable
2rkfB-1rrmA:
14.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  84
None
0.80A 2rkfB-1sivA:
18.6
2rkfB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
1.30A 2rkfB-1sivA:
18.6
2rkfB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.44A 2rkfB-1sivA:
18.6
2rkfB-1sivA:
51.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tdj BIOSYNTHETIC
THREONINE DEAMINASE


(Escherichia
coli)
PF00291
(PALP)
PF00585
(Thr_dehydrat_C)
5 GLY A 295
ALA A 294
ILE A 313
ALA A 239
ILE A 270
None
0.81A 2rkfB-1tdjA:
undetectable
2rkfB-1tdjA:
11.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
5 LEU A 184
GLY A 188
ALA A 189
ASP A 190
ILE A 158
None
0.79A 2rkfB-1to3A:
undetectable
2rkfB-1to3A:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w55 ISPD/ISPF
BIFUNCTIONAL ENZYME


(Campylobacter
jejuni)
PF01128
(IspD)
PF02542
(YgbB)
6 LEU A 300
GLY A 213
ALA A 256
ASP A 255
GLY A 262
ILE A 257
None
1.41A 2rkfB-1w55A:
undetectable
2rkfB-1w55A:
15.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y0y FRV OPERON PROTEIN
FRVX


(Pyrococcus
horikoshii)
PF05343
(Peptidase_M42)
5 LEU A 191
ALA A  67
ILE A  53
ALA A 194
ILE A 190
None
0.86A 2rkfB-1y0yA:
undetectable
2rkfB-1y0yA:
14.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zap SECRETED ASPARTIC
PROTEINASE


(Candida
albicans)
PF00026
(Asp)
5 LEU A 216
ASP A 218
GLY A 220
ALA A 303
ILE A 305
None
A70  A 500 ( 2.3A)
A70  A 500 (-3.3A)
A70  A 500 ( 3.8A)
A70  A 500 (-4.8A)
0.72A 2rkfB-1zapA:
7.8
2rkfB-1zapA:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zcc GLYCEROPHOSPHODIESTE
R PHOSPHODIESTERASE


(Agrobacterium
fabrum)
PF03009
(GDPD)
6 LEU A  24
GLY A  29
ALA A  30
ASP A  31
ILE A  33
ALA A  21
None
1.38A 2rkfB-1zccA:
undetectable
2rkfB-1zccA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zkd DUF185

(Rhodopseudomonas
palustris)
PF02636
(Methyltransf_28)
5 LEU A 225
ASP A 221
ASP A 279
ALA A 228
ILE A 224
None
0.87A 2rkfB-1zkdA:
undetectable
2rkfB-1zkdA:
12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a2f EXOCYST COMPLEX
COMPONENT SEC15


(Drosophila
melanogaster)
PF04091
(Sec15)
6 LEU X 239
ALA X 185
ASP X 184
GLY X 190
ILE X 193
ILE X 242
None
1.47A 2rkfB-2a2fX:
undetectable
2rkfB-2a2fX:
15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.68A 2rkfB-2bc0A:
undetectable
2rkfB-2bc0A:
12.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f31 DIAPHANOUS PROTEIN
HOMOLOG 1


(Mus musculus)
PF06367
(Drf_FH3)
PF06371
(Drf_GBD)
5 ALA A 238
ILE A 208
GLY A 231
ILE A 232
ILE A 209
None
0.88A 2rkfB-2f31A:
undetectable
2rkfB-2f31A:
18.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.37A 2rkfB-2fmbA:
15.1
2rkfB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.73A 2rkfB-2fmbA:
15.1
2rkfB-2fmbA:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g1s RENIN

(Homo sapiens)
PF00026
(Asp)
5 LEU A 219
ASP A 221
GLY A 223
ALA A 224
PRO A 301
None
4IG  A 885 (-2.6A)
4IG  A 885 (-3.9A)
4IG  A 885 ( 4.7A)
None
0.68A 2rkfB-2g1sA:
8.3
2rkfB-2g1sA:
14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g4r MOLYBDOPTERIN
BIOSYNTHESIS MOG
PROTEIN


(Mycobacterium
tuberculosis)
PF00994
(MoCF_biosynth)
5 GLY A 115
ASP A  97
GLY A 118
ILE A 125
ILE A  99
None
TRS  A 301 (-2.8A)
None
None
None
0.85A 2rkfB-2g4rA:
undetectable
2rkfB-2g4rA:
22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gd5 CHARGED
MULTIVESICULAR BODY
PROTEIN 3


(Homo sapiens)
PF03357
(Snf7)
5 LEU A 104
GLY A  90
ILE A 140
ALA A 137
ILE A 139
None
0.88A 2rkfB-2gd5A:
undetectable
2rkfB-2gd5A:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gzl 2-C-METHYL-D-ERYTHRI
TOL
2,4-CYCLODIPHOSPHATE
SYNTHASE


(Escherichia
coli)
PF02542
(YgbB)
6 GLY A  37
ASP A   8
ILE A  98
GLY A 145
PRO A 103
ILE A  20
None
ZN  A 900 ( 2.4A)
None
None
None
None
1.18A 2rkfB-2gzlA:
undetectable
2rkfB-2gzlA:
23.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hg4 6-DEOXYERYTHRONOLIDE
B SYNTHASE


(Saccharopolyspora
erythraea)
PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF08990
(Docking)
PF16197
(KAsynt_C_assoc)
6 LEU A 262
GLY A 259
ALA A 245
ASP A 247
ILE A  71
ALA A 263
None
1.35A 2rkfB-2hg4A:
undetectable
2rkfB-2hg4A:
8.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hpg ABC TRANSPORTER,
PERIPLASMIC
SUBSTRATE-BINDING
PROTEIN


(Thermotoga
maritima)
PF03480
(DctP)
5 LEU A 123
GLY A 272
ILE A 279
ALA A 119
ILE A 120
None
0.78A 2rkfB-2hpgA:
undetectable
2rkfB-2hpgA:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hyp HYPOTHETICAL PROTEIN
RV0805


(Mycobacterium
tuberculosis)
PF00149
(Metallophos)
6 ALA A  57
ASP A  56
ILE A 165
ILE A  19
ALA A 167
ILE A 129
None
1.40A 2rkfB-2hypA:
undetectable
2rkfB-2hypA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i5b PHOSPHOMETHYLPYRIMID
INE KINASE


(Bacillus
subtilis)
PF08543
(Phos_pyr_kin)
6 LEU A  66
ASP A  58
ILE A  57
ILE A  89
ALA A  37
ILE A  62
None
1.47A 2rkfB-2i5bA:
undetectable
2rkfB-2i5bA:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.79A 2rkfB-2isqA:
undetectable
2rkfB-2isqA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jfd FATTY ACID SYNTHASE

(Homo sapiens)
PF00698
(Acyl_transf_1)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.32A 2rkfB-2jfdA:
undetectable
2rkfB-2jfdA:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jfn GLUTAMATE RACEMASE

(Escherichia
coli)
PF01177
(Asp_Glu_race)
5 LEU A  25
ASP A 250
ILE A 253
ALA A  52
ILE A  50
None
0.86A 2rkfB-2jfnA:
undetectable
2rkfB-2jfnA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pp3 L-TALARATE/GALACTARA
TE DEHYDRATASE


(Salmonella
enterica)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
6 LEU A  33
GLY A  77
ILE A  89
GLY A 306
ALA A  93
ILE A  63
None
1.39A 2rkfB-2pp3A:
undetectable
2rkfB-2pp3A:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qzw CANDIDAPEPSIN-1

(Candida
albicans)
PF00026
(Asp)
5 LEU A 216
ASP A 218
GLY A 220
ALA A 303
ILE A 305
None
0.77A 2rkfB-2qzwA:
7.9
2rkfB-2qzwA:
16.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
ALA A  40
ASP A  41
ILE A  71
ILE A 108
None
1.36A 2rkfB-2rspA:
13.0
2rkfB-2rspA:
30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
7 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A  44
ILE A 108
None
0.36A 2rkfB-2rspA:
13.0
2rkfB-2rspA:
30.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
6 LEU A 243
GLY A 248
ALA A 249
ASP A 250
ASP A 251
ALA A 240
None
1.33A 2rkfB-2vn8A:
undetectable
2rkfB-2vn8A:
17.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wgh RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
LARGE SUBUNIT


(Homo sapiens)
PF00317
(Ribonuc_red_lgN)
PF02867
(Ribonuc_red_lgC)
5 GLY A 538
ALA A 539
ILE A 501
ALA A 447
ILE A 503
None
None
None
GOL  A1743 (-4.9A)
None
0.81A 2rkfB-2wghA:
undetectable
2rkfB-2wghA:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsk GLYCOGEN DEBRANCHING
ENZYME


(Escherichia
coli)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 188
GLY A 255
ALA A 254
ILE A 248
ILE A 185
None
0.81A 2rkfB-2wskA:
undetectable
2rkfB-2wskA:
9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x2g TRIOSEPHOSPHATE
ISOMERASE,
GLYCOSOMAL


(Trypanosoma
brucei)
PF00121
(TIM)
5 ALA A 125
ILE A 147
GLY A 128
ALA A 149
ILE A 150
None
0.85A 2rkfB-2x2gA:
undetectable
2rkfB-2x2gA:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xio PUTATIVE
DEOXYRIBONUCLEASE
TATDN1


(Homo sapiens)
PF01026
(TatD_DNase)
6 ASP A   8
GLY A  10
ASP A 222
ILE A 266
GLY A 194
ILE A 263
None
None
EDO  A1299 (-2.9A)
None
None
None
1.18A 2rkfB-2xioA:
undetectable
2rkfB-2xioA:
17.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z23 PERIPLASMIC
OLIGOPEPTIDE-BINDING
PROTEIN


(Yersinia pestis)
PF00496
(SBP_bac_5)
6 LEU A 374
ASP A 300
ILE A 301
GLY A 296
ALA A 377
ILE A 302
None
1.47A 2rkfB-2z23A:
undetectable
2rkfB-2z23A:
12.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a2q 6-AMINOHEXANOATE-CYC
LIC-DIMER HYDROLASE


(Arthrobacter
sp. KI72)
PF01425
(Amidase)
6 GLY A 283
ALA A 284
ILE A 453
GLY A 450
ILE A 449
ILE A 385
None
1.27A 2rkfB-3a2qA:
undetectable
2rkfB-3a2qA:
11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b48 UNCHARACTERIZED
PROTEIN


(Enterococcus
faecalis)
PF03610
(EIIA-man)
5 LEU A  65
GLY A 102
ALA A 103
ILE A  33
ILE A   5
None
0.76A 2rkfB-3b48A:
undetectable
2rkfB-3b48A:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e4e CYTOCHROME P450 2E1

(Homo sapiens)
PF00067
(p450)
5 ALA A 438
ILE A 115
GLY A 300
ILE A 180
ILE A 114
HEM  A 500 (-3.8A)
HEM  A 500 (-4.0A)
HEM  A 500 (-3.4A)
None
HEM  A 500 (-4.0A)
0.85A 2rkfB-3e4eA:
undetectable
2rkfB-3e4eA:
11.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f4n PYRIDOXINE
5'-PHOSPHATE
SYNTHASE


(Yersinia pestis)
PF03740
(PdxJ)
6 ALA A 136
ASP A 137
ILE A 152
GLY A 106
ALA A 191
ILE A 154
None
1.33A 2rkfB-3f4nA:
undetectable
2rkfB-3f4nA:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3faw RETICULOCYTE BINDING
PROTEIN


(Streptococcus
agalactiae)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
6 ALA A 847
ASP A 848
GLY A 830
ILE A 829
ALA A 815
ILE A 812
None
1.47A 2rkfB-3fawA:
undetectable
2rkfB-3fawA:
9.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fd0 PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE


(Listeria
innocua)
PF06838
(Met_gamma_lyase)
6 ALA A 217
ASP A 218
ILE A 219
GLY A 163
ALA A 221
ILE A 220
None
EDO  A 416 ( 4.8A)
None
None
None
None
1.33A 2rkfB-3fd0A:
undetectable
2rkfB-3fd0A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3frv CHARGED
MULTIVESICULAR BODY
PROTEIN 3


(Homo sapiens)
PF03357
(Snf7)
5 LEU A 104
GLY A  90
ILE A 140
ALA A 137
ILE A 139
None
0.84A 2rkfB-3frvA:
undetectable
2rkfB-3frvA:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
6 LEU A 148
GLY A 191
ALA A 213
ASP A 212
GLY A 256
ILE A 189
None
1.20A 2rkfB-3gf7A:
undetectable
2rkfB-3gf7A:
10.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gmi UPF0348 PROTEIN
MJ0951


(Methanocaldococcus
jannaschii)
PF05636
(HIGH_NTase1)
PF16581
(HIGH_NTase1_ass)
5 LEU A  62
GLY A 111
ALA A 112
ASP A 113
GLY A  73
None
0.88A 2rkfB-3gmiA:
undetectable
2rkfB-3gmiA:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.81A 2rkfB-3gveA:
undetectable
2rkfB-3gveA:
15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h2s PUTATIVE NADH-FLAVIN
REDUCTASE


(Lactobacillus
paracasei)
PF13460
(NAD_binding_10)
6 GLY A   7
ALA A  69
ASP A  68
ILE A 196
ALA A  20
ILE A  16
NDP  A 301 (-3.2A)
NDP  A 301 (-4.9A)
None
None
None
None
1.46A 2rkfB-3h2sA:
undetectable
2rkfB-3h2sA:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhd FATTY ACID SYNTHASE

(Homo sapiens)
PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc)
6 LEU A 567
ALA A 590
ASP A 591
GLY A 579
ILE A 495
ILE A 564
None
1.34A 2rkfB-3hhdA:
undetectable
2rkfB-3hhdA:
8.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hkz DNA-DIRECTED RNA
POLYMERASE SUBUNIT
A'


(Sulfolobus
solfataricus)
PF00623
(RNA_pol_Rpb1_2)
PF04983
(RNA_pol_Rpb1_3)
PF04997
(RNA_pol_Rpb1_1)
PF04998
(RNA_pol_Rpb1_5)
PF05000
(RNA_pol_Rpb1_4)
5 GLY A 712
ALA A 711
ILE A 665
GLY A 748
ILE A 661
None
0.88A 2rkfB-3hkzA:
2.7
2rkfB-3hkzA:
9.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
6 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
1.03A 2rkfB-3i5gA:
undetectable
2rkfB-3i5gA:
8.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.72A 2rkfB-3jv7A:
undetectable
2rkfB-3jv7A:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3khz PUTATIVE DIPEPTIDASE
SACOL1801


(Staphylococcus
aureus)
PF01546
(Peptidase_M20)
6 LEU A 130
GLY A  73
ALA A  72
GLY A  80
ALA A 126
ILE A 127
None
0.95A 2rkfB-3khzA:
undetectable
2rkfB-3khzA:
12.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kkl PROBABLE CHAPERONE
PROTEIN HSP33


(Saccharomyces
cerevisiae)
no annotation 6 LEU A 156
GLY A 159
ALA A 196
ILE A 210
PRO A 141
ILE A 157
None
1.35A 2rkfB-3kklA:
undetectable
2rkfB-3kklA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l0g NICOTINATE-NUCLEOTID
E PYROPHOSPHORYLASE


(Ehrlichia
chaffeensis)
PF01729
(QRPTase_C)
PF02749
(QRPTase_N)
6 LEU A  13
ILE A   8
GLY A  48
ILE A 102
ALA A  12
ILE A   9
None
1.23A 2rkfB-3l0gA:
undetectable
2rkfB-3l0gA:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l49 ABC SUGAR (RIBOSE)
TRANSPORTER,
PERIPLASMIC
SUBSTRATE-BINDING
SUBUNIT


(Rhodobacter
sphaeroides)
PF13407
(Peripla_BP_4)
5 LEU A 105
ILE A 113
GLY A  35
ILE A  36
ILE A 108
None
0.81A 2rkfB-3l49A:
undetectable
2rkfB-3l49A:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3la4 UREASE

(Canavalia
ensiformis)
PF00449
(Urease_alpha)
PF00547
(Urease_gamma)
PF00699
(Urease_beta)
PF01979
(Amidohydro_1)
6 GLY A 723
ALA A 703
ASP A 704
ILE A 357
GLY A 700
ILE A 359
None
1.45A 2rkfB-3la4A:
undetectable
2rkfB-3la4A:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdo PUTATIVE
PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Parabacteroides
distasonis)
PF02769
(AIRS_C)
6 LEU A 251
GLY A 256
ALA A 255
ASP A 246
ILE A 319
ILE A 248
None
1.10A 2rkfB-3mdoA:
undetectable
2rkfB-3mdoA:
14.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mwe ATP-CITRATE SYNTHASE

(Homo sapiens)
PF16114
(Citrate_bind)
5 LEU A 301
GLY A 296
ILE A 337
GLY A 416
ILE A 275
None
0.84A 2rkfB-3mweA:
undetectable
2rkfB-3mweA:
13.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
1.38A 2rkfB-3mwsA:
19.6
2rkfB-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
0.90A 2rkfB-3mwsA:
19.6
2rkfB-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
None
1.41A 2rkfB-3mwsA:
19.6
2rkfB-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
None
1.38A 2rkfB-3mwsA:
19.6
2rkfB-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.51A 2rkfB-3mwsA:
19.6
2rkfB-3mwsA:
70.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o04 BETA-KETO-ACYL
CARRIER PROTEIN
SYNTHASE II


(Listeria
monocytogenes)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
6 LEU A 354
ALA A  21
ASP A  20
ILE A 348
ALA A 350
ILE A 351
None
1.36A 2rkfB-3o04A:
undetectable
2rkfB-3o04A:
13.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o59 DNA POLYMERASE II
LARGE SUBUNIT


(Pyrococcus
horikoshii)
PF03833
(PolC_DP2)
6 LEU X 113
GLY X 116
ILE X  67
GLY X  59
ALA X  80
ILE X 112
None
1.49A 2rkfB-3o59X:
undetectable
2rkfB-3o59X:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 LEU A 724
GLY A 697
PRO A 615
ALA A 616
ILE A 695
None
0.87A 2rkfB-3opyA:
undetectable
2rkfB-3opyA:
8.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p9x PHOSPHORIBOSYLGLYCIN
AMIDE
FORMYLTRANSFERASE


(Bacillus
halodurans)
PF00551
(Formyl_trans_N)
6 LEU A  34
GLY A  88
ALA A  87
ILE A  18
ILE A 105
ILE A   6
None
1.33A 2rkfB-3p9xA:
undetectable
2rkfB-3p9xA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pqv RCL1 PROTEIN

(Kluyveromyces
lactis)
PF01137
(RTC)
PF05189
(RTC_insert)
5 LEU A 136
ALA A  99
ILE A 129
ALA A 131
ILE A 132
None
0.83A 2rkfB-3pqvA:
undetectable
2rkfB-3pqvA:
15.00